Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel is a specially compounded medication. This semisolid formulation is dispensed through a pump mechanism, allowing for easy and precise application on the skin. It is designed for targeted treatment or absorption of active ingredients in a gel-like consistency. It is used to treat conditions such as Overactive Bladder, Urge Incontinence, Neurogenic Detrusor Overactivity, Nocturnal Enuresis, and Fecal Incontinence.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present the compounded formulation of Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel. This unique combination of oxybutynin chloride and glycopyrrolate is specifically designed to alleviate symptoms associated with overactive bladder, urinary incontinence, and other bladder-related conditions. Oxybutynin chloride, an anticholinergic medication, functions by inhibiting the action of acetylcholine, a neurotransmitter that triggers bladder contractions. On the other hand, glycopyrrolate, an antimuscarinic medication, operates by blocking the action of muscarinic receptors, which are also responsible for bladder contractions. The synergistic effect of these two medications helps to decrease bladder contractions and enhance bladder control.
This compounded formulation is a semisolid preparation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients. The gel-like consistency ensures a smooth application process, allowing the active ingredients to be absorbed effectively. Patients are advised to apply the gel to the affected area twice daily, or as per the instructions of their healthcare provider.
At Bayview Pharmacy, we are dedicated to providing our patients with high-quality compounded medications. We understand that each patient is unique, and we strive to meet their individual needs through our personalized medication solutions. If you have any queries about Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel or any of our other compounded medications, please feel free to contact us. We are here to assist you in your journey towards better health.
Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel is a semisolid formulation dispensed through a pump mechanism, designed for easy and precise application on the skin. This targeted treatment is primarily used for the management of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency. It is also beneficial for treating neurogenic detrusor overactivity (NDO) in adults suffering from spinal cord injury or multiple sclerosis.
The combination of oxybutynin and glycopyrrolate in this formulation works synergistically to decrease the amount of urine your bladder can hold and reduce muscle spasms of the bladder. However, patients should be aware of potential side effects, which may include dry mouth, constipation, blurred vision, and dizziness. It is recommended to maintain adequate hydration while on this medication.
Additionally, this medication may cause drowsiness. Patients are advised not to drive or operate machinery until they are aware of how this medication affects them. Regular monitoring for signs of urinary retention or reduced gastric motility is necessary while taking this medication. Special attention should be given to signs of hyperthermia, especially in hot weather or during exercise.
Prescribers should note that this medication may interact with other medications, including anticholinergics, antispasmodics, and antidiarrheals. Therefore, a thorough review of the patient's medication list is crucial prior to prescribing this medication. If you have any questions about Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel, please do not hesitate to reach out.
Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel is a specially compounded medication designed to manage symptoms of overactive bladder and urge incontinence. This unique formulation works by inhibiting the action of acetylcholine, a neurotransmitter that triggers bladder contractions. By reducing the frequency of these contractions, the gel helps to alleviate the urge to urinate frequently.
The gel is dispensed through a pump mechanism, which allows for easy and precise application. It is designed to be applied directly to the skin, specifically on the abdomen, thigh, or upper arm. Once applied, the active ingredients are absorbed through the skin and enter the bloodstream, from where they are transported to the bladder to exert their therapeutic effects.
For optimal results, the gel should be applied once daily, ideally at the same time each day. It is crucial to apply the gel to clean, dry skin and to avoid contact with the eyes, mouth, and other mucous membranes. After application, hands should be washed thoroughly to prevent accidental transfer of the medication to other areas.
It's important to understand that Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel may take several weeks to achieve its full therapeutic effect. Additionally, like all medications, this gel may cause side effects, including dry mouth, constipation, and blurred vision. If you experience any of these or other side effects, it is recommended to contact your healthcare provider immediately.
If you have any questions or concerns about Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel or its mechanism of action, don't hesitate to reach out. We are here to provide the information and support you need to manage your health effectively.
Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel is a compounded formulation designed to alleviate symptoms associated with overactive bladder, such as urinary frequency, urgency, and urge incontinence. It may also be beneficial in treating neurogenic detrusor overactivity, nocturnal enuresis, and fecal incontinence. This semisolid formulation is dispensed through a pump mechanism, allowing for easy and precise application on the skin. The active ingredients are absorbed through the skin, providing targeted treatment and relief from symptoms.
It is crucial to note that this formulation should not be used by patients with a known hypersensitivity to either oxybutynin or glycopyrrolate. Additionally, this formulation may cause skin irritation in some individuals. Patients should be vigilant for any signs of skin irritation while using this product. If any signs of skin irritation occur, such as redness, itching, or swelling, the patient should immediately discontinue use and contact their healthcare provider.
If you have any questions or concerns about the use of Oxybutynin Chloride 10%/Glycopyrrolate 0.25% Topical Gel, please do not hesitate to reach out to us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
This is a compounded formulation of two active ingredients, Oxybutynin Chloride and Glycopyrrolate, in a semisolid gel form. It is designed for topical application on the skin.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The gel has a semisolid, gel-like consistency that facilitates targeted treatment or absorption of the active ingredients.
The gel is applied to the skin where it is absorbed. The active ingredients then work to provide the intended therapeutic effects.
The active ingredients in this formulation are Oxybutynin Chloride, which is present at a concentration of 10%, and Glycopyrrolate, which is present at a concentration of 0.25%.
Store the gel in a cool, dry place away from direct sunlight. Always ensure the cap is tightly closed after use to prevent the gel from drying out.
It is recommended to use the gel as directed by your healthcare provider. Avoid applying the gel on broken or irritated skin, or near the eyes, nose, or mouth.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to catch up.
If the gel is accidentally ingested, seek immediate medical attention. Keep the product out of reach of children to prevent accidental ingestion.
Consult your healthcare provider before using this product if you are pregnant, planning to become pregnant, or breastfeeding. The safety of this product for use during pregnancy or breastfeeding has not been established.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
